Note: Ingredients listed on restricted chemical lists
EC/CAS
75-09-2
Name of the chemical
Methylene chloride
Concentration
N/A
General Information
Revision date
2010-07-12
Product name
EPA Method 8270, CLP 8270 Additions Up To Revision 2 - Internal Standard Agilent
Emergency telephone
1-302-633-8777
Icons in SDS
Company Information
company name
Agilent Technologies, Inc
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Physical state Liquid. Odor : Chloroform-like Pleasant. OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200).
Signal word
WARNING!
Hazard statements
HARMFUL IF INHALED. INHALATION CAUSES HEADACHES, DIZZINESS, DROWSINESS AND NAUSEA AND MAY LEAD TO UNCONSCIOUSNESS. CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. MAY BE HARMFUL IF SWALLOWED. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA. POSSIBLE CANCER HAZARD - CONTAINS MATERIAL WHICH MAY CAUSE CANCER, BASED ON ANIMAL DATA.
Precautionary statements
Avoid exposure - obtain special instructions before use. Do not breathe vapor or mist. Do not ingest. Do not get in eyes or on skin or clothing. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use. Wash thoroughly after handling.
Principle Routes of Exposure
Ingestion.
Potential Acute Health Effects
Inhalation Toxic by inhalation. Can cause central nervous system (CNS) depression. Irritating to respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion Harmful if swallowed. Can cause central nervous system (CNS) depression. Skin Severely irritating to the skin. Eyes Severely irritating to eyes. Risk of serious damage to eyes.
Potential chronic health
effects : Contains material that may cause target organ damage, based on animal data. Carcinogenicity : Contains material which may cause cancer, based on animal data. Risk of cancer depends on duration and level of exposure. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: cardiovascular system, skin, central nervous system (CNS), eye, lens or cornea. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: nausea or vomiting respiratory tract irritation coughing headache drowsiness/fatigue dizziness/vertigo unconsciousness Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions Pre-existing disorders involving any target organs mentioned in this MSDS as being at aggravated by over- risk may be aggravated by over-exposure to this product. exposure See toxicological information (section 11)